Manufacturer of Controlled Substances; Notice of Application; Correction, 17471-17472 [05-6789]

Download as PDF Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices 17471 and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Schedule the public interest at this time. DEA has investigated Aldrich Chemical Company, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6794 Filed 4–5–05; 8:45 am] DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By notice dated December 21, 2004 and published in the Federal Register on January 4, 2005 (70 FR 389), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substances listed in Schedule II. The company plans to import the phenylacetone to manufacture amphetamine for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Cambrex Charles City, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) 18:17 Apr 05, 2005 Jkt 205001 BILLING CODE 4410–09–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Correction BILLING CODE 4410–09–P VerDate jul<14>2003 Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6797 Filed 4–5–05; 8:45 am] By Notice dated December 21, 2004, and published in the Federal Register on January 4, 2005, (70 FR 390), the listing of controlled substances N– Ethylamphetamine (1475), 2,5– Dimethoxyamphetamine (7396), 4– Methoxyamphetamine (7411), and Difenoxin (9168), were inadvertently added for Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409. The Notice of Application should be corrected by deleting N– Ethylamphetamine (1475), 2,5– Dimethoxyamphetamine (7396), 4– Methoxyamphetamine (7411), and Difenoxin (9168). Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6788 Filed 4–5–05; 8:45 am] BILLING CODE 4410–09–P Drug 2,5–Dimethoxyamphetamine (7396). 4–Methoxyamphetamine (7411) ... Difenoxin (9168) ........................... Methamphetamine (1105) ............ Raw Opium (9600) ....................... Concentrate of Poppy Straw (9670). I I I II II II The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. Sections 823(a) and 952(a) and determined that the registration of Cambrex Charles City, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. Sections 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6795 Filed 4–5–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration DEPARTMENT OF JUSTICE Importer of Controlled Substances; Notice of Registration Drug Enforcement Administration By Notice dated December 21, 2004 and published in the Federal Register on January 4, 2005, (70 FR 390), Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in Schedule I and II: Drug Schedule N–Ethylamphetamine (1475) ........ PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 I Manufacturer of Controlled Substances; Notice of Application; Correction By notice dated July 21, 2004, and published in the Federal Register on August 10, 2004 (69 FR 48522), Dade Behring Inc., Route 896 Corporate Boulevard, Building 100, Attention: RA/ QA, Post Office Box 6101, Newark, Delaware 19717 made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer, and to modify its address. The address modification was inadvertently omitted. The state of E:\FR\FM\06APN1.SGM 06APN1 17472 Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices Delaware renamed the road where the facility is located, thus causing the address to change. The address should be modified to read: Dade Behring Inc., 100 GBC Drive MS514, Post Office Box 6101, Attention: RA/QS, Newark, Delaware 19714–6101. Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6789 Filed 4–5–05; 8:45 am] Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6790 Filed 4–5–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By notice dated November 8, 2004, and published in the Federal Register on November 22, 2004 (69 FR 67963), ISP Freetown Fine Chemicals, 238 South Main Street, Assonet, Massachusetts 02702, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in Schedule II. The company plans to import Phenylacetone to be used in the manufacture of amphetamine. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of ISP Freetown Fine Chemicals to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated ISP Freetown Fine Chemicals to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. By notice dated February 17, 2005, and published in the Federal Register on February 28, 2005 (70 FR 9677– 9678), JFC Technologies, LLC, 100 West Main Street, PO Box 669, Bound Brook, New Jersey 08805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Meperidine-Intermediate B (9233), a basic class of controlled substance listed in Schedule II. The company plans to import the listed controlled substances for manufacture of controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of JFC Technologies, LLC to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated JFC Technologies, LLC to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6798 Filed 4–5–05; 8:45 am] BILLING CODE 4410–09–P VerDate jul<14>2003 18:17 Apr 05, 2005 Jkt 205001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Correction The Notice dated December 21, 2004, and published in the Federal Register on January 4, 2005, (70 FR 393), the drug code for Fentanyl was incorrect, for Organichem Corporation, 33 Riverside Avenue, Rensselaer, New York 12144. The correct drug code for Fentanyl is (9801). The Notice of Application should be corrected to reflect Fentanyl (9801). Dated: March 29, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–6793 Filed 4–5–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a registration under 21 U.S.C. 952 (a) (2) (B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on February 1, 2005, Penick Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in Schedules II: Drug Coca Leaves (9040) ..................... Raw Opium (9600) ....................... Poppy Straw (9650) ..................... Poppy Straw Concentrate (9670) Schedule II II II II The company plans to import the listed controlled substances to manufacturer bulk controlled substances and non-controlled substance flavor extracts. Any manufacturer who is presently, or is applying to be, registered with DEA E:\FR\FM\06APN1.SGM 06APN1

Agencies

[Federal Register Volume 70, Number 65 (Wednesday, April 6, 2005)]
[Notices]
[Pages 17471-17472]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6789]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Correction

    By notice dated July 21, 2004, and published in the Federal 
Register on August 10, 2004 (69 FR 48522), Dade Behring Inc., Route 896 
Corporate Boulevard, Building 100, Attention: RA/QA, Post Office Box 
6101, Newark, Delaware 19717 made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer, and to modify its address. The address modification was 
inadvertently omitted. The state of

[[Page 17472]]

Delaware renamed the road where the facility is located, thus causing 
the address to change. The address should be modified to read: Dade 
Behring Inc., 100 GBC Drive MS514, Post Office Box 6101, Attention: RA/
QS, Newark, Delaware 19714-6101.

    Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-6789 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.